Moratorium 2014 extension
October 3, 2012
THE moratorium on Cabinet
deferrals of the listing of some new
medicines on the Pharmaceutical
Benefits Scheme has been
extended to June 2014.
Speaking in the wake of the
announcement, Medicines Australia
Chief Executive Dr Brendan Shaw
said the move represented a step
forward, but that it did not provide
a lasting solution to a widely
critisised policy issue.
“It’s disappointing that the
Government hasn’t taken the
opportunity to put this issue to
bed,” said Shaw.
“There is still no commitment
from the Government to abandon
deferring medicines for PBS listing
deemed cost-effective by an expert
evaluation committee,” he added.
According to Shaw, because the
moratorium applies only to
medicines that will cost the PBS
less than $10 million a year,
“uncertainty remains for the listing
of other medicines on to the PBS”.
“Australia is a country that can
afford medicines for sick people
and should be giving timely access
to medicines a very high priority,”
he said.
“Deferrals mean patients are
denied access to the medicines
they need.
“The policy also creates
uncertainty for industry and makes
it harder for companies to bring
new medicines to Australia,
medicines that in many cases are
already available and subsidised in
other advanced economies,” he
added.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Oct 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Oct 12
Warning: Undefined variable $flipbook_id in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1259
Warning: Undefined variable $o_shortcode_atts in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1263
Warning: Undefined variable $output in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1266
